2026 Trials for Older Adults: Eligibility, Polypharmacy & Telehealth
Practical guidance for 2026 clinical trials: broaden eligibility for multimorbidity, reduce polypharmacy with targeted deprescribing, and scale home-based telehealth options—supported by 2024–2025 trial data and cost-effectiveness insights.
Robert Maxwell
Oct 20, 2025
geriatric oncology trials
polypharmacy management
Frailty assessment studies
Telehealth senior trials
